Shares of Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), a biopharmaceutical company engaged in the development and commercialization of products to treat diseases associated with inflammation, continued to rally in trading today.
Continue reading Big Gainer; Anthera Pharmaceuticals Inc. (ANTH)